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Introduction 
Breast cancer (BC) is a heterogeneous disease, con-
taining distinct disease subgroups that are associated 
with different morphological and immunohistochemical 
features and clinical behavior1. The historically used BC 
classification system combines histomorphological infor-
mation and Tumor, Node, Metastasis (TNM) staging in-
formation. BC are classified into at least 17 subtypes ac-
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A B S T R A C T
Breast cancer (BC) is a highly heterogeneous disease. Aim was to evaluate imaging features of triple negative breast 
cancers (TNBC) in comparison to non-TNBC. We reviewed data of 30 patients who had been diagnosed as having TNBC 
and 37 patients with non-TNBC (control group) using criteria described for mammography (MMG), ultrasound (US) and 
magnetic resonance imaging (MRI) in Breast Imaging-Reporting and Data System (BI-RADS) lexicon for image inter-
pretation. Age of patients, size of tumor, multifocality, histological type, tumor grade and status of lymph nodes were re-
viewed. TNBC were more often histological grade 3 and had significantly more positive lymph nodes at the time of diag-
nosis on pathology reports. On MMG, US and MRI TNBC mostly appeared as regularly shaped masses. On US as 
hypoechogenic masses with no posterior acoustic features and on MRI as masses with rim type of enhancement, fast 
wash-in and plateau type of curves. Most frequent category reported after MMG and US was BI RADS 4, and after MRI 
BI RADS 5. In conclusion, our study confirmed higher histological grade of TNBC, as well as more frequent lymph node 
involvement in comparation to the non-TNBC. TNBC showed tendency to affect younger women and to be larger than 
non-TNBC. Although, they most often presented as a mass on mammography and sonography, in a significant number 
of cases they remained miscategorized, due to the benign imaging features. All cases are recognized on MRI where they 
appear as rim enhancing masses. 
Key words: triple negative breast cancers, mammography, ultrasound, magnetic resonance imaging
cording to histopathological characteristics 2. The largest 
group of breast tumors (50–80%) are invasive breast car-
cinoma of no special type (IBC-NST)3.  In last two decades 
semiquantitative immunohistochemical classification is 
increasingly in use, suggested by St. Gallen International 
Expert Consensus panel, classifying BC into different mo-
lecular subtypes based on tumor markers expression sta-
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tus: estrogen receptor (ER), progesterone receptor (PR), 
human epidermal growth factor receptor-2 (HER2) over-
expression, and Ki-67 index4. All different BC molecular 
subtypes have different prognosis and treatment possibil-
ities. Triple-negative breast cancer (TNBC) is a distinctive 
sub-group of BC without expression of ER, PR or HER25. 
This BC phenotype demonstrates poor prognosis because 
of aggressive tumor biology, mutation of the p53 gene and 
a high degree of correlation with suppressed breast cancer 
gene (BRCA1) function. It contains 15% of all BC and 
there is no FDA-approved targeted therapies6. TNBC are 
typically large, high-grade tumors with high rates of re-
currence and distant metastasis, and low overall sur vival 
rates7,8. Additionally, recent literature data suggest that 
TNBC represent a heterogeneous sub-group of cancers 
with at least six subtypes. These subtypes are immuno-
modulatory (IM), luminal androgen receptor (LAR), bas-
al-like 1 (BL-1), basal-like 2 (BL-2), mesenchymal (M), 
and mesenchymal stem-like (MSL). They are categorized 
based upon their gene expression portfolio, markers for 
cytokeratin 5/6 and epidermal growth factor receptor 
(EGFR)7,9. Due to high malignancy potential of TNBC, 
early detection of this BC subtype is vital.
There are many reports in the literature regarding 
imaging of a TNBC, but this is to the best of our knowl-
edge, one of the first that will provide facts regarding all 
three breast imaging techniques with additional sec-
ond-look US. The aim of this study is to evaluate imaging 
features of TNBC and to look for some features that can 
help us to differentiate this type of BC from others.
Patients and Methods
We retrospectively reviewed reports and images of 
thirty patients who have been diagnosed as having TNBC 
in a three-year period at our Department. Hospital ethical 
committee approved study under the number IRB-12/2015. 
All women willing to participate signed an informed con-
sent. Only women, regardless of age, with biopsy proven 
ER, PR and HER 2 negative tumors that were evaluated 
with all three breast imaging techniques (mammography 
(MMG), ultrasonography (US) and magnetic resonance 
imaging (MRI)) were included in this study and they made 
the study group. The group consisted of 30 patients who 
presented with 41 tumors. As a control group, 37 BC pa-
tients evaluated with all three breast imaging techniques 
and with biopsy proven positive ER, PR and negative 
HER2 or positive ER, PR and overexpression of HER2 
were randomly selected in our database in the same peri-
od of time. In this non-TN group there were 37 patients 
with 45 tumors. All women who agreed to participate 
signed an informed consent form. Women diagnosed with 
any type of BC earlier in lifetime were excluded from the 
study, as were women who did not sign informed consent. 
We reviewed age of patients, size of tumor, multifocal-
ity, histological type, tumor grade and status of lymph 
nodes that we extracted from patient’s pathology reports. 
Standard two-view MMG was performed, using full 
flat-panel detector mammographic scanner (Mammomat 
Novation DR, Siemens, Erlangen, Germany). Breast US 
was performed by one well experienced breast radiologist 
(Aixplorer, Supersonic Imagine, Aix en Provance, France). 
Contrast enhanced breast MRI was performed by one 
well-experienced breast radiologists on a 1.5T MRI Sys-
tem (Magnetom Avanto, Siemens, Erlangen, Germany). 
Turbo-spin echo T2 transverse sequences were performed, 
followed by five fast 3D T1-weighted sequences performed 
after application of 0.2 ml/kg of contrast medium, that 
were subtracted to precontrast T1-weighted images. Dy-
namic contrast curves from enhancing masses were gen-
erated. 
Images of 30 patients with TNBC and 37 patients with 
non-TNBC were reviewed by highly experienced breast 
radiologists using morphological criteria described for 
MMG, US and MRI in the American College of Radiolo-
gy’s BI-RADS lexicon for image interpretation10.
For MMG we used description of presence of tumor 
(mass, mass and microcalcifications, microcalcifications, 
asymmetry and architectural distortion, asymmetry and 
architectural distortion with microcalcifications, no find-
ings – negative report and very dense breasts that obscure 
any findings), margins (well defined – sharp, circum-
scribed, distinct; ill defined – lobulated, spiculated, indis-
tinct), shape (regular – oval, round;  irregular), multifocal-
ity and BI RADS category. For US we used descriptions of 
presence of tumor (mass, mass and calcifications, calcifica-
tions, asymmetry and architectural distortion, asymmetry 
and architectural distortion with calcifications, no findings 
– negative report), echo pattern (hypo/hyper/complex le-
sions), margins (well defined/ill defined), shape (regular/
irregular), orientation (parallel/non parallel), multifocality, 
vascularity on color Doppler, posterior features and BI 
RADS category. For MRI we used descriptions of presence 
of tumor (mass, non-mass, mass with non-mass component, 
focus), margins (well defined/ill defined), shape (regular/
irregular), multifocality, internal enhancement character-
istics (homogeneous, heterogeneous, rim enhancement) and 
type of curve in first 2 minutes following intravenous bolus 
of contrast agent (slow and fast wash in) and after 2 min-
utes (persistent, plateau, fast wash out).
Statistical analysis
Categorical data are represented by absolute and rel-
ative frequencies. Differences of categorical variables were 
tested by χ2 test and by Fisher’s exact test. The normali-
ty of the distribution of numerical variables was tested by 
the Shapiro-Wilk test. Differences between two indepen-
dent groups were tested by Mann-Whitney’s U test. All p 
values were two-sided. The level of significance was set to 
Alpha = 0.05. The analysis was conducted while using the 
MedCalc® Statistical Software version 19.6 (MedCalc 
Software Ltd, Ostend, Belgium; https://www.medcalc.org; 
2020) and the IBM SPSS 23 (IBM Corp.Released 2015. 
IBM SPSS Statistics for Windows, Version 23.0. Armonk, 
NY: IBM Corp.)
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Results
Selected demographic and clinical characteristics of 
patients 
There was no statistically significant difference in age 
(p=0.6), presentation as multifocal/unifocal and size of 
tumors (data not shown). Regarding histological grade, 
22% of TNBC were grade 2 and 78% were grade 3. In non-
TN group 40% tumors presented as grade 1, 42% as grade 
2 and 18% as grade 3 (χ2; p<0.001, Table 1). TNBC were 
more often histological grade 3 (χ2; p<0.001). TNBC had 
significantly positive lymph nodes on pathology reports 
(χ2; p=0.003, Table 1).
80% of TNBC were invasive ductal cancer of NST, 7% 
were IDC with ductal in situ component, 2% were ductal 
carcinoma in situ (DCIS), 2% were ductolobular type and 
7% was ductal medullar histological type. There was sta-
tistically significant difference (χ2; p=0.03) comparing to 
non-TN group in which there were 53% of ductal NST, 9% 
ductal cribriform type, 4% ductal tubular type, 13% IDC 
with DCIS component, 4% DCIS, 4% ductal comedo type, 
2% ductolobular, 9% ductolobular invasive with ductal in 
situ component and no medullar type (Table 1). 
Mammographic features of TNBC
Mammography (MMG) appearance of tumor, accord-
ing to American College of Radiology’s BI-RADS lexicon 
for image interpretation, was devided into seven catego-
ries. There was no statistical significant difference in 
MMG appearance between TNBC and non-TNBC (χ2; 
p=0.43, Table 2). 
Regarding tumor margins, 39% of TNBC presented 
as a mass with well defined  margins (Fisher exact test; 
p=0.03) and 61% of TNBC had ill defined margins. 
Abovementioned was significantly different comparing 
to the control group with 94% of non-TNBC with ill de-
fined margins (Fisher exact test; p=0.03, Table 2). 
There was a statistical significant difference in lesion/
mass shape between TN and non-TN group. TNBC had 
significantly more regular shape compared to control 
group (Fisher exact test; p=0.03, Table 2). 
Compared to control group TNBC were significantly 
more multifocal (Fisher exact test; p<0.001). 
There was no statistical significant difference in BI-
RADS categorization regarding MMG presentation be-
tween TN and non-TN group (χ2; p=0.34, Table 2).
TABLE 1






Number of patients 37 (55) 30 (45)
Number of tumors 45 (52) 41 (48)
Age , years [Median (25%–75%)] 56 (47-61) 52 (45–61) 0.60†
HISTOLOGICAL GRADE 
1 18 (40) 0 <0.001*
2 19 (42) 9 (22)
3 8 (18) 32 (78)
MULTIFOCAL/UNIFOCAL PRESENTATION 
Multifocal 17 (38) 21 (51) 0.17*
Unifocal 28 (62) 20 (49)
Number of BC with positive lymph nodes 15 (33) 27 (66) 0.003*
PATHO-HISTOLOGICAL DIAGNOSIS 
Ductal NST 24 (53) 33 (80) 0.01*
Ductal cribriform 4 (9) 0 0.12*
Ductal tubular 2 (4) 0 0.50*
Ductal invasive with in situ component 6 (13) 3 (7) 0.49*
Ductal carcinoma in situ 2 (4) 1 (2) > 0.99*
Ductal comedo 2 (4) 0 0.49*
Ductolobular 1 (2) 1 (2) > 0.99*
Ductolobular invasive with in situ component 4 (9) 0 0.12*
Ductal medullar 0 3 (7) 0.10*
BC – breast cancer, TNBC – triple negative breast cancer, PhD – patho-histological diagnosis; NST – no special type
*χ2 test; †Mann Whitney U test 
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Sonographic features of TNBC
Ultrasound appearance (US) of tumors, according to 
American College of Radiology’s BI-RADS lexicon for image 
interpretation, was divided in six categories. There was no 
statistical significant difference in ultrasound appearance 
between TN and non-TN group (χ2; p=0.26, Table 3). 
Regarding tumor margins, TNBC have had signifi-
cantly more often circumscribed margins in regards to 
non-TN tumors, out of which 94% have had not circum-
scribed margins, (Fisher exact test; p<0.001, Table 3).
Regarding shape of tumors, TNBC more often have 
had regular shape (53%) (Fisher exact test; p=0.004, Ta-
ble 3). 
There was no statistical significant difference in orien-
tation, echo pattern, posterior features, vascularity and 
unifocal/multifocal presentation between TN and non-TN 
group (χ2; p=0.3) (Fisher exact test; p=0.8, Table 3).
There was no statistical significant difference accord-
ing to BI RADS category after ultrasound examination 
between TN and non-TN group (χ2; p=0.29, Table 3).
MRI features of TNBC
Tumor appearance on MRI, according to American Col-
lege of Radiology’s BI RADS lexicon for image interpretation, 
was divided in four categories. In TN group 83% tumors 
presented as an enhancing masses (χ2; p=0.03, Table 4). 
Well defined borders on MRI showed 41% of TNBC 
(Fisher exact test; p=0.008) (Table 4). There was no statis-
tically significant difference in lesion/mass shape between 
TN and non-TN group (Fisher exact test; p=0.24, Table 4).
TNBC most often presents as lesion with rim enhance-
ment after bolus of intravenous contrast admission (Fisher 
exact test; p<0.001, Table 4). There was a statistically signif-
icant difference in tumors type of curve in first 2 minutes 
TABLE 2






Number of tumors 45 (52) 41 (48)
APPEARANCE ON MAMMOGRAPHY 
Mass 17 (38) 19 (47) 0.43*
Mass with microcalcifications 1 (2) 4 (10)
Microcalcifications 7 (16) 4 (10)
Asymmetry and architectural distortion 7 (16) 4 (10)
Asymmetry and architect. distortion with microcalci-
fication
1 (2) 2 (5)
Negative for suspect lesions 10 (22) 8 (20)
Very dense breasts – further examination required 2 (4) 0
MARGINS 
Well defined 1 (6) 9 (39) 0.03†
Ill defined 17 (94) 14 (61)
SHAPE 
Regular 3 (17) 12 (52) 0.03†
Irregular 15 (83) 11 (48)
MULTIFOCAL/UNIFOCAL PRESENTATION 
Multifocal 2 (7) 10 (30) 0.02*
Unifocal 29 (94) 23 (70)
BI RADS categorization 
0 2 (5) 0 0.34*
1 1 (3) 2 (6)
2 3 (7) 0
3 3 (7) 5 (14)
4 18 (46) 17 (49)
5 12 (31) 11 (31)
TNBC – triple negative breast cancer, BI RADS – breast imaging reporting and data system, 
*χ2 test, †Fisher’s exact test
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TABLE 3






Number of tumors 45 (52) 41 (48)
APPEARANCE ON ULTRASOUND 
Mass 25 (56) 29 (71) 0.26*
Mass with microcalcifications 8 (18) 3 (7)
Microcalcifications 0 0
Asymmetry and architectural distortion 5 (11) 1 (2)
Asymmetry and architect. distortion with microcalcification 2 (4) 3 (7)
Negative for suspect lesions 5 (11) 5 (12)
MARGINS 
Circumscribed 2 (6) 16 (50) <0.001†
Not circumscribed 31 (94) 16 (50)
SHAPE 
Regular 6 (18) 17 (53) 0.004†
Irregular 27 (82) 15 (47)
ORIENTATION
Paralel 9 (27) 8 (25) >0.99†
Non paralel 24 (73) 24 (75)
ECHO PATTERN 
Hyperechoic 1 (3) 0 0.30*
Complex lesions (cystic and solid) 9 (24) 5 (14)
Hypoechoic 27 (73) 31 (86)
POSTERIOR FEATURES 
Without any 18 (49) 19 (53) 0.82†
Shadowing 19 (51) 17 (47)
VASCULARITY 
Visible 26 (67) 25 (71) 0.80†
Absent 13 (33) 10 (29)
MULTIFOCAL/UNIFOCAL PRESENATION
Multifocal 7 (18) 14 (39) 0.07*
Unifocal 32 (82) 22 (61)
BI RADS CATEGORIZATION 
1 2 (5) 1 (3) 0.29*
3 1 (2) 2 (5)
4 15 (36) 20 (54)
5 24 (57) 14 (38)
TNBC – triple negative breast cancer, BI RADS – breast imaging reporting and data system
* χ2 test; †Fisher’s exact test
after contrast admission between TN and non-TN group 
(Fisher exact test; p=0.02, Table 4). In first 2 minutes after 
contrast admission majority (83%) of TNBC have had fast 
wash in type of curve, that is 17% of TNBC showed slow wash 
in, while 98% non-TNBC have had fast wash in type of curve. 
There was no statistical significant difference in type of dy-
namic MRI curve after first two minutes after contrast ad-
mission between TN and non-TN group (χ2; p=0.06, Table 4).
There was no statistical significant difference in tu-
mors presented as a unifocal/multifocal according to 
MRI between TN and non-TN group (Fisher exact test; 
p=0.28, Table 4). 
There was no statistical significant difference accord-
ing to BI RADS category after MRI examination be-
tween TN and non-TN group (χ2; p=0.18, Table 4). 
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Discussion 
We demonstrated importance of MRI in confident de-
tection of TNBC and characteristics of tumors when diag-
nosing with currently available methods. Generally, 
TNBC occurred in younger patients. The average size of 
TBNC tumors was bigger and they tend to be multifocal. 
This trend did not reach statistical significance, mainly 
due to limited sample size. In line with our finding, pre-
vious studies showed that TNBC were associated with 
younger age and bigger size11. TNBC more often appear as 
ductal medullar type than non –TN, and medullar type is 
the most common after IDC NST among TNBC. The re-
sults of our study regarding TNBC being more often his-
tological grade 3 are in line with previously published 
research, which is a consequence of the more aggressive 
biologic behavior of TNBC11. 
We had four patients with TNBC with DCIS compo-
nent, three of them were invasive cancers with in situ 
component, while one case was DCIS only. This is consis-
tent with the observation that TNBC rarely appear as 
DCIS only 12, because of their aggressive behavior and 
rapid carcinogenesis that bypasses the in situ stage. Be-
cause of that, MMG as screening method, as we demon-
strated, has limited value in diagnosing patients who are 
TABLE 4
MRI FINDINGS OF BC PATIENTS
Control TNBC p value
Number of tumors 45 (52) 41 (48)
APPEARANCE ON MRI 
Mass enhancemenet 26 (58) 34 (83) 0.03*
Mass enhancemenet  + non mass component 8 (18) 3 (7)
Non mass enhancemenet 10 (22) 2 (5)
Focus 1 (2) 2 (5)
BORDERS  
Well defined 4 (12) 15 (41) 0.008†
Ill defined 30 (88) 22 (59)
SHAPE 
Regular 13 (38) 20 (54) 0.24†
Irregular 21 (62) 17 (46)
INTERNAL ENHANCEMENT CHARACTERISTICS 
Homogeneous 22 (50) 12 (31) <0.001†
Heterogeneous 21 (68) 11 (28)
Rim enhancement 1 (2) 16 (41)
FIRST 2 MINUTES AFTER CONTRAST ADMISSION 
Slow wash in 1 (2) 7 (17) 0.02†
Fast wash in 44 (98) 34 (83)
AFTER FIRST 2 MINUTES AFTER CONTRAST ADMISSION  
Persistent 1 (2) 7 (17) 0.06*
Plateau 27 (60) 20 (49)
Fast wash out 17 (38) 14 (34)
MULTIFOCAL/UNIFOCAL PRESENTATION  
Multifocal 17 (38) 21 (51) 0.28†
Unifocal 28 (62) 20 (49)
BI RADS MRI 
3 1 (2) 5 (12) 0.18*
4 23 (51) 17 (42)
5 21 (47) 19 (46)
MRI – magnetic resonance imaging; TNBC – triple negative breast cancer, 
BI RADS – breast imaging reporting and data system 
*χ2 test; †Fisher’s exact test
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at increased risk of developing TNBC. According to our 
findings TNBC often presented on MMG as mass of reg-
ular shape with well-defined margins (47%, 52%, 39% 
respectively) (Figure 1). Most important, negative MMG 
finding was every fifth examination, possibly due to the 
proportion of multifocal tumors that were not visualized 
on MMG, and as a consequence of benign appearance and 
dense breast tissue in women median age of 52. Third 
most common appearance on MMG was the mass with 
microcalcifications, microcalcifications only and asymme-
try or architectural distortion. Less common appearances 
were calcifications only or asymmetry maybe due to the 
small incidence of in situ carcinoma, as we mentioned ear-
lier. Most common MMG category was BIRADS 4 (48.6%), 
then BI RADS 5 (31.4%) and BIRADS 3 (14.3%). Large 
number of BIRADS 3 and BIRADS 4 findings was due to 
benign appearance of breast lesions, which were well de-
fined and have regular shape on MMG. Data from this 
study suggested that MMG alone is suboptimal method 
for diagnosing TNBC, consistently with other studies13,14. 
Wen et al. reported that TN group of tumors detected by 
MMG were characterized with smooth margins and, when 
rarely represented as calcifications, these calcifications 
were benign15.
On US half of TNBC appeared as hypoechogenic mass 
with regular shape and well-defined borders, without pos-
terior acoustic features. Majority had non parallel orien-
tation and visible blood flow on color Doppler examination. 
Similar benign and intermediate US findings were 
demonstrated previously 16, 17. US report was negative for 
suspicious lesions in 12% of cases, which is better than 
MMG but still many cancers could be overlooked. 
With “second look” targeted US after MRI all cancers 
found on MRI were visualized by US. This is an advantage 
of US in comparison to MMG. On the initial US examina-
tions some tumors with very subtle findings were missed, 
in spite of examinations being performed by experienced 
sonologists, these lesions were noted only on targeted, sec-
ond look examination. Statistical analysis confirmed as 
sonographic discriminators for TNBC: regular shape and 
well-defined margins (Figure 2).
Fig. 1. Mammographic features of TNBC: mass with regular 
(oval) shape and well-defined margins in one part and 
ill-defined borders in one smaller part of lesion.
Fig. 2.  Ultrasound features of TNBC: mass with regular shape 
and well defined margins.
Our results regarding MRI presentation of TNBC are 
in line with previously published emphasizing TNBC ap-
pearance as regular shaped masses with rim enhance-
ment, fast wash in, followed by plateau18, 19. Interestingly, 
17% of cases showed slow wash in and 17% presented with 
persistent type of curve (benign dynamic features) after 
first two minutes, which was not the case in non-TNBC 
group. We had similar proportion of cases reported as BI 
RADS 4 and 5 (more than 40% each) but also considerable 
number of cases was reported as BI RADS 3 (12%), pre-
sumably consequence of benign features of TNBC18. Our 
study showed MRI signature of TNBC as regular shaped 
mass, with rim type of enhancement and fast wash in type 
of dynamic curve in first two minutes after contrast ad-
mission (Figures 3 and 4). 
A major limitation of our study is small number of pa-
tients, which could cause discrepancies with other studies, 
for example age and size of TNBC when comparing them 
to non-TNBC. Additionally, retrospective design of study 
aggravated objective assessment of BI RADS category. 
However, to the best of our knowledge, this is one of the 
first studies that utilized all three breast imaging tech-
niques with second-look US and had a control group of 
non-TNBC. Given the accelerated development of artificial 
intelligence, in further research US texture analysis could 
be included. Recent study showed that US texture analy-
sis provided an objective adjunct diagnostic tool, improv-
ing the diagnostic efficiency in the differential diagnosis 
of TNBC from non-TNBC20.
In conclusion, TNBC tend to affect younger women and 
are bigger in size than non-TNBC. They are mostly IDC 
NST or medullar type, and histological grade 3. Most com-
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Fig. 3. MRI features of triple negative breast cancer: regular shaped mass with rim 
type of enhancement.
Fig. 4. Features of MRI dynamic curves that are more often associated with triple 
negative breast cancers: in first 2 minutes after contrast admission fast wash in and 
after first 2 minutes persistent and plateau type of curve. 
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mon presentation of TNBC is a regular shaped mass with 
slightly more often ill-defined margins. In many cases 
they are not recognized on MMG and US. However, all 
tumors are visible on MRI, appearing typically as mass 
with ill-defined margins, regular shape and rim type of 
enhancement. 
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ZNAČAJKE SNIMKI TROSTRUKO NEGATIVNIH KARCINOMA DOJKE – MAMOGRAFIJA, 
ULTRAZVUK I MAGNETSKA REZONANCIJA
S A Ž E T A K
Rak dojke (RD) vrlo je heterogena bolest. Cilj istraživanja bio je procijeniti slikovne značajke trostrukog  negativnog 
karcinoma dojke (TNRD) u usporedbi s ne-TNRD-om. Pregledali smo podatke 30 pacijenata kojima je dijagnosticiran 
TNRD te 37 pacijenata s ne-TNRD-om (kontrolna skupina) koristeći kriterije opisane za mamografiju (MMG), ultrazvuk 
(US) i magnetsku rezonancu (MRI) u Breast Imaging-Reporting and Data System (BI-RADS) za interpretaciju slike. 
Analizirana je dob pacijenata, veličina tumora, multifokalnost, histološki tip, gradus tumora i status limfnih čvorova. 
TNRD-i su češće bili histološki gradus 3 i znatno su više imali pozitivne limfne čvorove u vrijeme dijagnoze na patohis-
tološkim izvješćima. Na MMG-u, US-u i MRI-u TNRD-i su se uglavnom pojavljivali kao pravilno oblikovane mase, na 
US-u kao hipoehogene mase bez stražnjih akustičnih značajki, a na MRI-u kao mase koje rubno nakupljaju kontrasno 
sredstvo, uz dinamičke krivulje s brzim nakupljanjem i platoom. Najčešća kategorija zabilježena nakon MMG-a i US-a 
bila je BI RADS 4, a nakon MRI-a BI RADS 5. U zaključku je naša studija potvrdila viši histološki gradus TNRD-a, 
kao i češće zahvaćanje limfnih čvorova u odnosu na kontrolnu skupinu. Pokazali smo tendenciju pojavljivanja kod mlađih 
žena, kao I veće dimezije u odnosu na kontrolnu skupinu. Iako su se najčešće predstavljali kao tvorba na MMG-a i US-
u, u određenome broju slučajeva pogrešno su kategorizirani zbog benignih slikovnih značajki. Svi su slučajevi na MRI-u 
dijagnosticirani kao masa koja rubno nakuplja kontrastno sredstvo. 
